Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5192_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Dedications
- •Contributors
- •Acknowledgments
- •Preface
- •1 Basic science
- •1.1 Structure and function of the skin
- •Epidermis
- •Cellular biology of the epidermis
- •Dermal cells of importance
- •Structural components and cell biology of the dermis
- •1.2 Embryology
- •1.3 Wound healing
- •Dermis
- •1.4 Genetics
- •Basic cell biology of genome
- •Inheritance patterns
- •1.5 Ultraviolet light
- •Ultraviolet light (Fig. 1.8)
- •Minimal erythema dose
- •1.6 Immunology
- •Innate immunity
- •Adaptive immunity
- •1.6.2 Immunologic mediators
- •Cytokines
- •Pattern recognition receptors
- •Antimicrobial proteins (AMPs)
- •The complement system
- •B cells
- •T cells (majority of lymphocytes)
- •Innate lymphoid cells
- •NK cells
- •Mononuclear phagocytes
- •Langerhans cells
- •Dendritic cells
- •Mast cells
- •Eosinophils
- •Neutrophils
- •1.6.4 Major histocompatibility complex
- •1.7 Laboratory techniques
- •1.7.1 Tissue acquisition and processing
- •Polymerase chain reaction (PCR)
- •Quantitative reverse transcriptase PCR (qRT-PCR)
- •16S ribosomal RNA (rRNA) sequencing
- •DNA sequencing
- •RNA sequencing
- •Fluorescence in situ hybridization (FISH)
- •Immunohistochemistry (IHC)
- •Enzyme-linked immunosorbent assay (ELISA)
- •1.7.3 Cellular engineering and gene therapy
- •2 Dermatopharmacology
- •2.1 ANTIHISTAMINES
- •Mechanism
- •Other antihistamines
- •Introduction
- •Mucocutaneous
- •Systemic
- •Teratogenicity
- •Contraindications
- •Interactions
- •2.3 CORTICOSTEROIDS
- •Hypothalamic-pituitary-adrenal (HPA) axis suppression (Box 2.1)
- •Psychiatric changes
- •Contraindications
- •Pregnancy
- •Clinical use
- •Intramuscular CS
- •Pulse IV CS
- •Adalimumab
- •Certolizumab pegol
- •Golimumab
- •Indications
- •Ustekinumab
- •IL-17 inhibitors
- •IL-23 inhibitors
- •Spesolimab
- •Rituximab
- •IL-1 inhibitors
- •Omalizumab
- •Dupilumab
- •Lebrikizumab and tralokinumab
- •Nemolizumab
- •Vismodegib and sonidegib
- •Intralesional CS
- •Monitoring
- •2.4 IMMUNOMODULATORY AGENTS
- •Apremilast and other PDE-4 inhibitors
- •Janus Kinase (JAK) and Tyro inhibitors
- •Agents used in dermatology
- •Laboratory monitoring
- •Azathioprine
- •Important monitoring points
- •Cyclosporine
- •Important pharmacology points
- •Indications
- •Important monitoring points
- •Methotrexate
- •Important pharmacology points
- •Indications and contraindications
- •Important monitoring points
- •Important pharmacology points
- •Indications
- •Monitoring guidelines
- •Cytotoxic agents
- •Hydroxyurea
- •Cyclophosphamide
- •Chlorambucil
- •Antimalarial agents
- •Important pharmacology points
- •Indications
- •Dapsone
- •Important pharmacology points
- •Indications
- •Important monitoring points
- •Etanercept
- •MEK inhibitors (trametinib, cobimetinib, binimetinib)
- •Ipilimumab
- •PD-1 inhibitors (pembrolizumab, nivolumab, cemiplimab) and PD-L1 inhibitors (avelumab, atezolizumab)
- •Imatinib mesylate
- •Ibrutinib
- •Talimogene
- •Mechlorethamine hydrochloride
- •Brentuximab vedotin
- •Mogamulizumab
- •Romidepsin and vorinostat
- •2.6 ANTIMICROBIAL AGENTS
- •Topical antibacterial agents
- •Bacitracin
- •Benzoyl peroxide
- •Metronidazole
- •Azelaic acid
- •Systemic antibacterial agents
- •Penicillins
- •Polymyxin B
- •Neomycin
- •Mupirocin
- •Retapamulin
- •Gentamicin
- •Iodoquinol
- •Cephalosporins
- •Vancomycin
- •Macrolides
- •Fluoroquinolones
- •Tetracyclines
- •Clindamycin
- •Carbapenems
- •Linezolid
- •Daptomycin
- •Others
- •Antiviral agents
- •Acyclovir
- •Valacyclovir
- •Famciclovir and penciclovir
- •Foscarnet
- •Bleomycin
- •Podophyllin resin and podophyllotoxin
- •Cantharidin
- •Sinecatechins
- •5-Fluorouracil and imiquimod (discussed in section 2.5)
- •I. Azoles
- •Itraconazole
- •Fluconazole
- •Ketoconazole
- •Voriconazole
- •Posaconazole
- •Miconazole, clotrimazole, and econazole
- •Efnaconazole
- •Luliconazole
- •II. Allylamines/benzylamines
- •Terbinafne
- •Butenafne
- •IV. Ciclopirox olamine
- •VI. Nystatin
- •VIII. Tavaborole
- •Antiparasitic agents (Tables 2.7 and 2.8)
- •2.7 PHOTOTHERAPY
- •UVA modalities
- •Psoralen plus UVA (PUVA)
- •UVA-1 (340–400 nm)
- •UVB modalities
- •Extracorporeal photochemotherapy
- •Photodynamic therapy (PDT)
- •2.8 MISCELLANEOUS AGENTS
- •Sunscreens
- •Topical cosmetic agents
- •Bimatoprost
- •Brimonidine and oxymetazoline
- •Hydroquinone
- •Psychiatric agents
- •Antiandrogens and androgen inhibitors
- •Spironolactone
- •Finasteride and dutasteride
- •Combination oral contraceptive pills
- •Clascoterone
- •Calcipotriene and calcitriol
- •Attenuated androgens
- •Danazol and stanozolol
- •Colchicine
- •Potassium iodide
- •Thalidomide
- •Topical calcineurin inhibitors
- •Pimecrolimus and tacrolimus
- •Intravenous immunoglobulin (IVIG)
- •Glycopyrrolate
- •Oxybutynin
- •Botulinum toxin
- •Aluminum chloride
- •2.9 DRUG INTERACTIONS AND THE CYTOCHROME P-450 SYSTEM
- •Key points
- •CYP1A2
- •CYP2C9
- •CYP2D6
- •CYP3A4 (most relevant to dermatologists)
- •Classic CYP mnemonics
- •2.10 DRUG REACTIONS
- •Urticaria, angioedema, and anaphylaxis
- •Fixed drug eruption/Stevens-Johnson syndrome/toxic epidermal necrolysis
- •Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS)
- •Acute generalized exanthematous pustulosis (AGEP)
- •Photosensitive drug reactions
- •Drug-induced pigmentary changes
- •Bullous drug reactions, lichenoid drug eruptions, drug-induced connective tissue disease
- •Other drug eruptions
- •3 General dermatology
- •3.1 Papulosquamous dermatoses
- •3.2 Eczematous dermatoses
- •3.3 Interface dermatitis
- •Vacuolar interface dermatitis
- •Autoimmune connective tissue disease (AICTD)
- •Erythema multiforme (EM)
- •Stevens-johnson syndrome (SJS), and toxic epidermal necrolysis (TEN, lyell’s syndrome)
- •Pityriasis lichenoides
- •Fixed drug eruption (FDE)
- •Graft- versus- host disease (GVHD)
- •Lichenoid interface dermatitis
- •Lichen planus (LP)
- •Keratosis lichenoides chronica (KLC)
- •Erythema dyschromicum perstans (ashy dermatosis)
- •Lichenoid keratosis (benign lichenoid keratosis [BLK], LP-like keratosis)
- •Lichen nitidus
- •3.4 Blistering diseases
- •Pemphigus disease family
- •Pemphigus vulgaris (PV)
- •Pemphigus foliaceus (PF)
- •Paraneoplastic pemphigus (PNP)/paraneoplastic autoimmune multiorgan syndrome (PAMS)
- •Autoimmune subepidermal blistering diseases
- •Bullous pemphigoid (BP; pemphigoid)
- •Mucous membrane pemphigoid (MMP; cicatricial pemphigoid)
- •Linear IgA bullous dermatosis/chronic bullous disease of childhood (LABD/CBDC)
- •Epidermolysis bullosa acquisita
- •Bullous systemic lupus erythematosus
- •Dermatitis herpetiformis (duhring disease)
- •Inherited blistering diseases
- •Epidermolysis bullosa (see chapter 4)
- •Darier disease (keratosis follicularis)
- •Other blistering diseases
- •Lupus band test (LBT)
- •Lupus erythematosus
- •Chronic cutaneous lupus erythematosus (CCLE)
- •Subacute cutaneous lupus erythematosus
- •Acute cutaneous lupus erythematosus (ACLE)
- •Other rare cutaneous lupus variants
- •Systemic lupus erythematosus (SLE)
- •Drug-induced SLE (DI-SLE)
- •Lupus-related diseases
- •Other autoimmune connective tissue diseases and sclerosing dermopathies
- •Dermatomyositis (DM)
- •Sjögren’s syndrome
- •Relapsing polychondritis
- •Mixed connective tissue disease (MCTD)
- •Rheumatoid arthritis
- •Systemic-onset juvenile idiopathic arthritis (still’s disease)
- •Morphea (localized scleroderma)
- •Eosinophilic fasciitis (shulman syndrome)
- •Abnormalities of connective tissue
- •3.6 Granulomatous/histiocytic disorders
- •Non-infectious granulomas
- •Granuloma annulare (GA)
- •Annular elastolytic giant cell granuloma (actinic granuloma of O’Brien
- •Interstitial granulomatous dermatitis and arthritis (IGDA) and palisaded neutrophilic granulomatous dermatitis (PNGD)
- •Interstitial granulomatous drug eruption
- •Necrobiosis lipoidica (necrobiosis lipoidica diabeticorum, NLD)
- •Necrobiotic xanthogranuloma (NXG)
- •Cutaneous crohn’s disease
- •Sarcoidosis
- •Histiocytoses
- •Langerhans cell histiocytosis (LCH)
- •Non-langerhans cell histiocytoses (discussed in Table 3.23)
- •Malignant histiocytic disorders
- •3.7 Monoclonal gammopathies of dermatologic interest
- •3.8 Xanthomas
- •3.9 Urticaria and angioedema
- •3.10 Neutrophilic dermatoses
- •Amicrobial pustulosis of the folds
- •3.11 Eosinophilic disorders
- •Granuloma faciale
- •Eosinophilic folliculitis
- •Papuloerythroderma of ofuji
- •Wells’ syndrome (eosinophilic cellulitis)
- •Hypereosinophilic syndrome (HES)
- •3.12 Figurate erythemas
- •3.13 Follicular and eccrine/apocrine disorders
- •Acne variants
- •Acne fulminans
- •Acne conglobata
- •Solid facial edema in acne
- •Acne mechanica
- •Neonatal acne (neonatal cephalic pustulosis)
- •Infantile acne
- •Transverse nasal crease
- •Acne in setting of endocrinologic abnormality
- •Acne cosmetica
- •Pomade acne
- •Chloracne
- •Radiation acne
- •Acneiform eruptions
- •Drug-induced acne
- •Acne-associated syndromes
- •SAPHO (chronic recurrent multifocal osteomyelitis)
- •PAPA
- •HAIR-AN
- •Apert syndrome (acrocephalosyndactyly)
- •Rosacea
- •Epidemiology
- •Rosacea subtypes
- •Erythematotelangiectatic (vascular)
- •Phymatous
- •Ocular
- •Rosacea variants
- •Solid facial edema in rosacea (morbihan disease and rosacea lymphedema)
- •Pyoderma faciale (rosacea fulminans)
- •Granulomatous rosacea
- •Lupus miliaris disseminatus faciei
- •Folliculitis
- •Gram-negative folliculitis
- •Hot tub folliculitis
- •Eosinophilic folliculitis
- •Disseminate and recurrent infundibulofolliculitis
- •Viral-associated trichodysplasia
- •Pseudofolliculitis barbae
- •Acne keloidalis nuchae
- •Follicular occlusion tetrad (acne conglobata, hidradenitis suppurativa, dissecting cellulitis of the scalp, and pilonidal cyst)
- •Hidradenitis suppurativa (acne inversa)
- •Pilonidal cyst
- •Dissecting cellulitis of the scalp and acne conglobata (discussed in alopecia and acne sections)
- •Other diseases of eccrine and apocrine sweat glands
- •Hyperhidrosis
- •Hypohidrosis and anhidrosis
- •Miliaria
- •Bromhidrosis
- •Chromhidrosis
- •Fox-fordyce disease (apocrine miliaria)
- •3.14 Drug reactions
- •3.15 Photodermatoses and other physical dermatoses
- •Temperature-related dermatoses
- •Thermal burns
- •Erythema ab igne
- •Cold injuries
- •Photoaging
- •Polymorphous light eruption
- •Hydroa vacciniforme (see Chapter 4)
- •Actinic folliculitis
- •Chronic actinic dermatitis
- •Actinic prurigo (see chapter 4)
- •Solar urticaria
- •Mechanical injuries
- •3.17 Neurodermatology and psychodermatology
- •Cutaneous manifestations of psychiatric illness or self-induction
- •Delusions of parasitosis
- •Excoriation disorder (neurotic excoriations)
- •Factitial dermatitis/dermatitis artefacta
- •Gardner-diamond syndrome
- •Body dysmorphic disorder
- •Cupping/coining
- •Other neurocutaneous dermatoses
- •Scalp dysesthesia/burning scalp syndrome
- •Burning mouth syndrome
- •Brachioradial pruritus
- •Notalgia paresthetica
- •Meralgia paresthetica
- •Trigeminal trophic syndrome
- •Familial dysautonomia/riley-day syndrome
- •Auriculotemporal nerve syndrome (frey syndrome)
- •3.18 Palmoplantar keratodermas
- •3.19 Nutritional disorders in dermatology
- •3.21 Ulcers (Table 3.33)
- •3.22 Vasculitides, vasculopathies, and other vascular disorders
- •Subtypes of cutaneous small vessel vasculitis
- •Henoch-schonlein purpura (HSP)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Key features of adult HSP
- •Key features of childhood HSP
- •Treatment
- •Laboratory testing: See CSVV section
- •Pathology
- •Acute hemorrhagic edema of infancy (Fig 3.86)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Treatment
- •Urticarial vasculitis
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory testing
- •Treatment (Table 3.41)
- •Erythema elevatum diutinum
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Treatment
- •Mixed cryoglobulinemia (see cryoglobulinemia section)
- •Small to medium vessel vasculitis
- •Granulomatosis with polyangiitis (wegener)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Treatment
- •Microscopic polyangiitis (MPA)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory testing: See CSVV, especially:
- •Treatment
- •Eosinophilic granulomatosis with polyangiitis (churg-strauss syndrome)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation: Three classic stages (Table 3.47)
- •Pathology
- •Laboratory testing
- •Treatment
- •Medium vessel vasculitis
- •Subtypes: PAN and kawasaki’s disease
- •Polyarteritis nodosa
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory testing: See CSVV
- •Treatment
- •Kawasaki disease (acute febrile mucocutaneous lymph node syndrome)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation (Fig. 3.90)
- •Laboratory testing
- •Treatment
- •Key testing facts
- •Large vessel vasculitis
- •Subtypes: Temporal arteritis and Takayasu’s arteritis
- •Temporal arteritis (giant cell arteritis)
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory workup
- •Treatment
- •Takayasu’s arteritis
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Laboratory workup
- •Treatment
- •Summary of organ system involvement in various vasculitides (Table 3.49)
- •Cryoglobulinemias
- •Epidemiology
- •Thrombosis and thrombotic syndromes
- •Important subtypes
- •Calciphylaxis
- •Antiphospholipid syndrome
- •Epidemiology
- •Pathophysiology
- •Clinical presentation
- •Pathology
- •Treatment
- •Pathogenesis
- •Clinical presentation
- •Pathology
- •Treatment
- •Other vasculopathies (Table 3.51)
- •Other vascular disorders
- •Venous lake
- •Telangiectasia
- •Erythromelalgia
- •Livedo reticularis (LR)
- •Angiospastic macules (bier spots)
- •3.23 Panniculitides and lipodystrophies
- •3.24 Dermatoses of pregnancy
- •3.25 Hair, nail, and mucosal disorders
- •Non-scarring alopecia
- •Androgenetic alopecia
- •Trichotillomania
- •Alopecia areata
- •Temporal triangular alopecia
- •Congenital atrichia with papules
- •Cicatricial (scarring) alopecia
- •Central centrifugal cicatricial alopecia
- •Lichen planopilaris
- •Acne keloidalis nuchae
- •Dissecting cellulitis of the scalp (perifolliculitis capitis abscedens et suffodiens)
- •Folliculitis decalvans
- •Traction alopecia
- •Hair shaft abnormalities
- •Hypertrichosis and hirsutism
- •Hypertrichosis
- •Nail disorders
- •Mucosal disorders
- •3.26 Pigmentary disorders
- •Disorders of hypopigmentation and depigmentation
- •Vitiligo
- •Halo nevus
- •Chemical and physical agent-induced hypopigmentation
- •Idiopathic guttate hypomelanosis
- •Progressive macular hypomelanosis
- •Nevus anemicus
- •Pigmentary mosaicism
- •Hypomelanosis of ito
- •Nevus depigmentosus
- •Disorders of hyperpigmentation
- •Melasma
- •Erythema dyschromicum perstans (ashy dermatosis) discussed in Section 3.3
- •Lichen planus pigmentosus
- •Linear and whorled nevoid hypermelanosis
- •Prurigo pigmentosa
- •Familial progressive hyperpigmentation
- •Endocrinopathies
- •Pigmentary demarcation lines (aka futcher’s lines, voight lines, ito’s lines)
- •4 Pediatric dermatology
- •4.1 Neonatal dermatology
- •4.2 Viral exanthems and select infectious disorders of childhood
- •4.3 Inherited pigmentary disorders
- •Hypo-/depigmentation
- •Pigmentary mosaicism
- •Oculocutaneous albinism (OCA)
- •Silvery hair syndromes
- •Griscelli syndrome
- •Hermansky-Pudlak syndrome
- •Piebaldism
- •Waardenburg syndrome
- •Hyperpigmentation
- •McCune-Albright syndrome
- •Lentiginoses syndromes
- •Hereditary dyschromatoses
- •Dyschromatosis symmetrica hereditaria (acropigmentation of Dohi)
- •Dyschromatosis universalis hereditaria
- •Naegeli-Franceschetti-Jadassohn syndrome (NFJS)/dermatopathia pigmentosa reticularis (DPR)
- •4.4 Epidermolysis bullosa
- •4.5 Tumor syndromes
- •4.6 Vascular tumors, malformations, and related vascular disorders
- •Vascular tumors
- •Phace syndrome
- •LUMBAR/SACRAL syndrome
- •Multiple hemangiomas
- •Kasabach-Merritt phenomenon
- •Vascular malformations
- •Capillary malformations (CM)
- •Sturge-Weber syndrome (encephalotrigeminal angiomatosis)
- •Phakomatosis pigmentovascularis
- •Phakomatosis pigmentokeratotica
- •PIK3CA-related overgrowth spectrum (PROS)
- •Klippel-trenaunay syndrome
- •Macrocephaly capillary malformation syndrome
- •Cloves syndrome
- •Proteus syndrome
- •Beckwith-wiedemann syndrome
- •Diffuse capillary malformation with overgrowth (DCMO)
- •Venous malformations
- •Maffucci syndrome (enchondromas with multiple angiomas)
- •Blue rubber bleb nevus syndrome
- •Glomulovenous malformations (GVMs; previously termed “glomangiomas”)
- •Lymphatic malformations
- •Macrocystic lymphatic malformations (cystic hygroma)
- •Gorham-stout (disappearing bone) disease
- •Congenital lymphedema (hereditary congenital lymphedema, Nonne-Milroy syndrome)
- •Arteriovenous malformations
- •AVMs
- •Parkes-weber syndrome
- •Cobb syndrome (cutaneomeningospinal angiomatosis)
- •Other vascular disorders
- •4.7 Disorders of hair and nails
- •Pachyonychia congenita
- •Ectodermal dysplasias
- •Hypohidrotic ectodermal dysplasia (Christ-Siemens-Touraine syndrome)
- •Hidrotic ectodermal dysplasia (Clouston syndrome)
- •Ectodermal dysplasias due to p63 mutation
- •Schöpf-Schulz-Passarge syndrome
- •Other disorders
- •Rubinstein-Taybi syndrome
- •Parakeratosis pustulosa
- •Congenital malalignment of the great toenails
- •4.8 Inherited metabolic and nutritional disorders
- •4.9 Inherited connective tissue disorders
- •4.10 Autoinflammatory disorders (periodic fever syndromes)
- •4.12 Premature aging syndromes and DNA repair disorders
- •4.13 Primary immunodeficiency disorders with cutaneous manifestations
- •4.14 Disorders of cornification
- •Actinic prurigo
- •Diaper dermatitis
- •Juvenile plantar dermatosis
- •Acropustulosis of infancy
- •Trichorhinophalangeal syndrome
- •Midas syndrome (also MLS or microphthalmia with linear skin defects)
- •H syndrome
- •Cutaneous mastocytosis
- •Neutrophilic eccrine hidradenitis of childhood
- •5 Infectious diseases
- •5.1 Viral diseases
- •Herpes simplex virus (HHV-1/HSV-1 and HHV-2/HSV-2)
- •Varicella zoster virus (VZV; HHV-3)
- •Epstein-Barr virus (HHV-4)
- •Cytomegalovirus (HHV-5)
- •HHV-6 (Roseola infantum, exanthem subitum, sixth disease)
- •HHV-7
- •HHV-8
- •Poxviruses
- •Zika virus
- •Dengue virus
- •Viral hepatitides (Table 5.2)
- •Viral-associated trichodysplasia of immunosuppression
- •COVID-19
- •5.2 HIV/AIDS dermatology
- •5.3 Bacterial infections
- •Staphylococcal skin infections
- •Corynebacterial skin infections
- •Clostridium skin infections
- •Filamentous bacteria
- •Other gram-positive infections
- •Pseudomonas
- •Bartonella
- •Rickettsia
- •Other gram-negative skin infections
- •Borrelia
- •Nonvenereal (endemic) treponematoses
- •Syphilis
- •Cutaneous tuberculosis
- •Leprosy (hansen’s disease)
- •Atypical mycobacteria
- •Tinea versicolor (pityriasis versicolor)
- •Piedra
- •Tinea nigra
- •Sporotrichosis
- •Lobomycosis
- •Mycetoma (madura foot)
- •Chromoblastomycosis
- •Histoplasmosis
- •Blastomycosis (“north American blastomycosis”)
- •Coccidioidomycosis
- •Paracoccidioidomycosis (“South American blastomycosis”)
- •Candidiasis
- •Cryptococcosis
- •Aspergillosis
- •Fusarium
- •Penicilliosis
- •Zygomycosis (mucormycosis)
- •Phaeohyphomycosis
- •Protothecosis
- •Rhinosporidiosis
- •5.5 Parasites and other creatures
- •Parasitic infestations
- •Scabies
- •Lice
- •Tungiasis
- •Myiasis
- •Protozoa
- •Leishmaniasis
- •Toxoplasmosis
- •Helminths
- •Cutaneous larva migrans
- •Larva currens
- •Onchocerciasis (“river blindness”)
- •Loiasis
- •Filariasis
- •Swimmer’s itch and seabather’s eruption
- •Trichinosis
- •Dracunculiasis (guinea worm)
- •Gnathosomiasis
- •Cysticercosis
- •Cutaneous amebiasis
- •Free-living amoeba
- •Gi-associated amoeba
- •Bites and stings
- •Biting and stinging insects
- •Arachnids (ticks, mites, spiders, and scorpions)
- •Millipedes and centipedes
- •Snake bites
- •6 Neoplastic dermatology
- •Neoplastic dermatology
- •6.1 Keratinocytic neoplasms
- •Premalignant/malignant
- •Actinic keratosis (AK)
- •Bowen’s disease (squamous cell carcinoma in situ)
- •Invasive cutaneous squamous cell carcinoma (cSCC, “SCC”)
- •Verrucous carcinoma
- •Keratoacanthoma
- •Basal cell carcinoma
- •6.2 Cysts
- •6.3 Melanocytic neoplasms
- •6.4 Adnexal neoplasms and hamartomas
- •Comparative dermatopathologic features of sweat gland neoplasms for board exam purposes
- •Poroma (classic juxtaepidermal type)
- •Hidroacanthoma simplex
- •Dermal duct tumor
- •Hidradenoma
- •Spiradenoma
- •Cylindroma
- •Syringoma
- •Mixed tumor (MT; “chondroid syringoma”)
- •Hidradenoma papilliferum (HPAP)
- •Syringocystadenoma papilliferum (SPAP, SCAP)
- •Papillary eccrine adenoma (PEA)
- •Tubular apocrine adenoma (TAA)
- •Porokeratotic eccrine ostial and dermal duct nevus
- •Microcystic adnexal carcinoma (MAC)
- •Aggressive digital papillary adenocarcinoma (ADPA)
- •Adenoid cystic carcinoma (ACC)
- •6.5 Hair follicle neoplasms/hamartomas
- •Folliculo-sebaceous-apocrine hamartomas
- •Trichofolliculoma
- •Fibrofolliculoma
- •Nevus sebaceus
- •Neoplasms with follicular germinative differentiation
- •Trichoepithelioma
- •Neoplasms with follicular matrix differentiation
- •Pilomatricoma (calcifying epithelioma of malherbe)
- •Neoplasms with follicular sheath (trichilemmal) differentiation
- •Trichilemmoma
- •Desmoplastic trichilemmoma (DTL)
- •Tumor of the follicular infundibulum (TFI)
- •Trichoadenoma (TA; of Nikolowski)
- •Proliferating pilar (trichilemmal) tumor
- •6.6 Sebaceous proliferations
- •6.7 Neural neoplasms
- •6.8 Smooth muscle neoplasms
- •6.9 Hematolymphoid neoplasms
- •6.10 Fibrohistiocytic neoplasms
- •Multinucleate cell angiohistiocytoma
- •Nodular fasciitis
- •Fibrous hamartoma of infancy
- •Giant cell tumor of tendon sheath (tenosynovial giant cell tumor)
- •Connective tissue nevus (collagenoma and elastoma)
- •6.11 Vascular proliferations
- •Benign vascular lesions
- •Vascular malformation (includes “port wine stain,” “cavernous hemangioma” old terminology)
- •Intravascular papillary endothelial hyperplasia (masson tumor, pseudoangiosarcoma)
- •Angiokeratoma
- •Infantile hemangioma
- •Pyogenic granuloma (lobular capillary hemangioma)
- •Epithelioid hemangioma (angiolymphoid hyperplasia with eosinophils, ALHE)
- •Targetoid hemosiderotic lymphatic malformation (hobnail hemangioma, targetoid hemosiderotic hemangioma)
- •Tufted angioma
- •Glomeruloid hemangioma
- •Glomus tumor/glomangioma
- •Borderline vascular neoplasms
- •Kaposiform hemangioendothelioma
- •Kaposi sarcoma (KS)
- •Other borderline vascular neoplasms (rare; not commonly tested)
- •High-grade malignant vascular neoplasms
- •Angiosarcoma
- •Vascular neoplasm associations
- •6.12 Neoplasms of adipocytic lineage
- •6.13 Dermoscopy
- •Seborrheic keratosis
- •Actinic keratosis
- •Basal cell carcinoma
- •Squamous cell carcinoma in situ
- •Squamous cell carcinoma
- •Ink spot lentigo
- •Vascular lesions (e.g., cherry angiomas)
- •Hemorrhage
- •Porokeratosis
- •Sebaceous hyperplasia
- •Dermoscopic patterns of melanocytic lesions
- •7 Dermatopathology
- •7.1 Essential concepts in dermatopathology
- •7.2 High-yield dermatopathology diagnoses at a glance
- •7.3 High-yield dermatopathology differential diagnoses
- •8 Dermatologic surgery
- •8.1 Surgical anatomy
- •8.2 Local anesthetics and perioperative pain control
- •8.3 Surgical instruments and needles
- •8.4 Suture techniques
- •8.5 Wound closure materials
- •8.7 Electrosurgery
- •8.8 Cryosurgery
- •8.9 Excisions
- •8.10 Mohs surgery
- •8.11 Flaps
- •8.12 Grafts
- •8.13 Surgical complications and measures to avoid them
- •8.14 Scar improvement
- •8.15 Nail surgery
- •8.16 Wound dressings
- •9 Cosmetic dermatology
- •9.1 Lasers

7.3 High-Yield Dermatopathology Differential Diagnoses
COMMON LOCALIZATION OF AUTOANTIBODIES IN INDIRECT
IMMUNOFLOURESCENCE MICROSCOPY STUDIES OF SALT-SPLIT SKIN
Basal keratinocytes
Bullous pemphigoid
Lamina lucida
Lamina densa
Sublamina densa
Fig. 7.15 Common localization of autoantibodies in indirect immunouorescence microscopy studies of salt-split skin. Subregions of salt-split skin commonly bound
by circulating autoantibodies in patients with subepidermal immunobullous diseases. (From Yancey KB. The biology of the basement membrane. In: Bolognia JL,
Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia: Elsevier; 2018:483–493.)
Pemphigoid gestationis
Linear IgA bullous dermatosis
Cicatricial pemphigoid
Anti-epiligrin
cicatricial pemphigoid
Epidermolysis bullosa acquisita
The bullous eruption of
systemic lupus
erythematosus
7.2 HIGH-YIELD DERMATOPATHOLOGY DIAGNOSES AT A GLANCE
• Herein, we present an abbreviated summary of the 226
most testable dermpath diagnoses, including their most
essential histopathologic features, as well as their mimics
(Table 7.11). Because of space constraints, we are unable to
include microscopic images of all entities. We encourage
the reader to refer to one of the many excellent Elsevier
Dermatopathology titles.
7.3 HIGH-YIELD DERMATOPATHOLOGY
DIFFERENTIAL DIAGNOSES
• See Tables 7.12 to 7.38
Table 7.12 “Normal Skin” DDx
Macular amyloid Light pink deposits papillary dermis; pigment
TMEP
Tinea corporis Pale-staining hyphae in lower stratum corneum,
Tinea versicolor Basaloid spores and hyphae (“spaghetti and
Argyria Small black granules in sweat glands
Ichthyosis vulgaris Compact orthohyperkeratosis w/ paradoxically
Erythrasma Organisms one-fifth the size of hyphae; vertical
incontinence/melanophages
Superficial dermal telangiectasias 1 sparse
proliferation of spindled mast cells; may need
CD117 immunostain or other mast cell stain (Leder,
Tryptase, or Giemsa) to confirm (Fig. 7.16)
brisk dermal inflammation, 1/– subcorneal pustule
meatballs”) in upper stratum corneum, much
easier to see than tinea corporis on H&E, and
minimal to no dermal inflammation
↓ granular layer (almost all other diseases w/
orthohyperkeratosis have ↑ granular layer)
filaments in stratum corneum
Fig. 7.16 Telangiectasia macularis eruptiva perstans. Microscopic changes are
subtle, with a sparse perivascular inltrate of mast cells that often require demonstration by immunohistochemistry.
415

CHAPTER 7 • Dermatopathology
Table 7.13 Busy Dermis DDx (Mnemonic: Busy Dermis Can Kill Grandma’s Sweet Niece Lucy)
Blue nevus Paucicellular dendritic melanocyte proliferation within sclerotic stroma , melanophages, and HMB-45 diffusely positive
Dermatofibroma Interstitial spindle cell proliferation in “curlicue pattern,” collagen trapping, epidermal/follicular induction, hemosiderin-laden
Cutaneous metastasis Most commonly tested: metastatic breast cancer (“single-cell filing,” small ducts), RCC (clear cells, highly vascular), colon
Kaposi sarcoma (plaque
stage)
GA (interstitial)
Scleromyxedema
Neurofibroma
Leukemia cutis Interstitial infiltrate of atypical cells w/ “ blast” morphology (fine chromatin, prominent nucleoli, and larger than normal inflammatory
(vs. gradient staining in conventional nevi) (Fig. 7.17)
1
histiocytes/Touton-like GCs, Factor XIIIa
cancer (“dirty necrosis”); although not always true, a rule of thumb to help determine primary tumor location is: CK71 (above
diaphragm), versus CK201 (below diaphragm) (Figs. 7.19–7.21 )
Relatively bland interstitial spindle cell proliferation , “promontory sign ,” vascular wrapping, thin slit-like vascular
spaces, extravasated RBCs, hemosiderin, and increased plasma cells (most easily seen in perivascular distribution
near tumor); HHV-81 (Fig. 7.22)
Interstitial histiocytes w/ foci of altered collagen, ↑ mucin, perivascular lymphocytes with eosinophils (Fig 7.23)
Bland dermal spindled fibroblastic proliferation w/ fine collagen fibers; ↑ mucin (Fig 7.24)
Loosely arranged spindle cells with wavy/ “buckled” nuclei , myxoid stroma, and ↑ mast cells (see Fig. 7.25)
cells) arranged in single-cell filing pattern; frequent mitoses ; myeloid/monocytic leukemias typically positive for CD68 and
lysozyme (two most sensitive markers) . MPO . CD34 and CD117 (see Fig. 7.26)
and CD34 (Figs. 7.18)
A B
Fig. 7.17 (A) and (B) Blue nevus. Spindled melanocytes with dendritic processes and cytoplasmic melanin are present between the dermal collagen bundles, which
are often brotic.
A B
Fig. 7.18 (A) Dermatobroma. Scanning section shows the characteristic architecture. The lateral borders of the lesion interdigitate with the adjacent dermis (so-called
“collagen trapping”). The overlying epidermis often shows induction (either epidermal hyperplasia, epidermal hyperpigmentation, hyperkeratosis, or potentially basaloid
or sebaceous differentiation). (B) Dermatobroma, ankle-type. Hemosiderin-laden Touton giant cells (ringed siderophages) are prominent.
416

7.3 High-Yield Dermatopathology Differential Diagnoses
A B
Fig. 7.19 (A) Metastatic breast adenocarcinoma, interstitial type. Atypical cells are seen coursing through the dermis single-le, and duct formation is noted. Breast
adenocarcinoma is typically immunoreactive for CK7 stain, with variable expression of ER, PR, and Her2neu. CK20 is usually negative. (B) Metastatic breast adenocarcinoma, inammatory type. Tumor aggregates are noted within dermal lymphatics.
Fig. 7.20 Metastatic colon adenocarcinoma. Dirty necrosis is seen within gland lumina. Colon cancer may stain for CK20 and CDX2; CK7 is usually negative.
A B
Fig. 7.21 (A) and (B) Metastatic renal cell carcinoma (RCC). Atypical clear cells forming ducts with a highly vascular stroma are noted. RCC may stain with keratin
markers such as AE1/AE3, RCC stain, CD10, and PAX8.
417

CHAPTER 7 • Dermatopathology
A
B
Fig. 7.22 Kaposi sarcoma (KS; patch stage; (A) H&E; (B) HHV-8 immunohistochemistry
stain). Increased vascularity, spindled cells with adjacent vascular spaces, hemosiderin
deposition, and intermixed plasma cells. The promontory sign, in which new blood
vessel formation is observed within larger vessels, may be present. KS is uniformly immunoreactive for HHV-8 by immunohistochemistry.
A
B
Fig. 7.23 Interstitial granuloma annulare. Increased interstitial histiocytes with
abundant interstitial mucin are seen within the dermis (part of the “busy dermis”
differential).
418
C
Fig. 7.24 Scleromyxedema (lichen myxedematosus A): Dermal brosis with increased broblasts (marked with CD34; B) is noted, along with separation of
collagen bers by increased dermal mucin (marked with colloidal iron stain, C).

7.3 High-Yield Dermatopathology Differential Diagnoses
A
Fig. 7.25 Neurobroma (NF), shown at low (A) and high (B) power. This neoplasm is composed of spindled cells with “s-shaped” nuclei. The associated collagen has
a “shredded carrot” appearance (B). Mast cells are usually scattered within the neoplasm. NF is S100 positive and also may stain with CD34.
Fig. 7.26 Acute myeloid leukemia involving the skin. There is a dense inltrate of blasts (dispersed chromatin, nuclear molding), some of which contain conspicuous
eosinophilic granules. The blasts usually are immunoreactive for myeloperoxidase, TdT, CD33, CD34, and CD117 (cKit) immunostains.
B
Table 7.14 Vacuolar Interface Dermatitis DDx
Lupus erythematosus
(SCLE)
Lupus erythematosus
(discoid)
Dermatomyositis
Erythema multiforme Basket-weave (acute) stratum corneum, prominent apoptotic keratinocytes scattered throughout all levels of epidermis, superficial
Fixed drug eruption Basket-weave (acute) stratum corneum, EM-like vacuolar interface, chronic dermal changes (deeper pigment incontinence,
Acute GVHD Orthohyperkeratosis, EM-like vacuolar interface, keratinocyte dysmaturation (from chemo effect), “satellite cell necrosis”;
PLEVA
Orthohyperkeratosis; brisk vacuolar interface diffusely affecting epidermis, superficial (. deep) PV/PA lymphocytic infiltrate ,
BMZ thickening, ↑ mucin; lacks eosinophils (Fig. 7.27)
Orthohyperkeratosis; moderate vacuolar interface centered around follicular epithelium (. interfollicular epidermis),
hyperplastic follicular infundibulae (esp. hypertrophic DLE), dilated follicles w/ follicular plugging, interfollicular epidermal atrophy,
dermal fibrosis/scar, superficial and deep PV/PA lymphocytic infiltrate, BMZ thickening, and ↑ mucin; lacks eosinophils (Fig. 7.28)
Orthohyperkeratosis, epidermal atrophy, sparse lymphocytic infiltrate (,LE), minimal vacuolar interface (,LE, EM, FDE, and PLEVA),
hhh
dermal mucin (>>LE) and vascular ectasia (telangiectasias); lacks deep PV/PA inflammation (vs. LE), lacks eosinophils (Fig. 7.29)
lymphocytic infiltrate w/ lymphocyte exocytosis; lacks eosinophils (vs. frequent eosinophils in SJS/TEN and FDE) (Fig. 7.30)
papillary dermal fibrosis), and mixed dermal inflammation w/ numerous eosinophils
frequently involves follicular and other adnexal epithelium (Fig. 7.31)
Parakeratosis, Lichenoid-to-vacuolar interface, Erythrocyte extravasation, V-shaped (wedge) lymphocytic infiltrate, Acute surface
changes (scale crust 1/– ulceration); never has eosinophils (if more than a few eosinophils present n not PLEVA!) (Fig. 7.32A,B)
419

CHAPTER 7 • Dermatopathology
Fig. 7.27 Subacute cutaneous lupus erythematosus. Vacuolar interface inammation
with perivascular mononuclear inammation. Increased dermal mucin and perifollicular
lymphocytic inammation are often noted. Follicular plugging is a feature seen more
frequently in chronic cutaneous lupus erythematosus (discoid lupus; not shown).
Fig. 7.28 Discoid lupus exhibits follicular plugging, supercial and deep perivascular and perifollicular lymphocytes. There is interfollicular atrophy and interface
dermatitis affecting both the epidermis and follicular epithelium. (From Fung MA.
Inammatory diseases of the dermis and epidermis. In: Busam KJ, ed. Dermatopathology: A Volume in the Series: Foundations in Diagnostic Pathology, 2nd ed.
Philadelphia: Elsevier; 2016, pp 11-78.)
Fig. 7.30 Erythema multiforme. This process is characterized by a basket-weave
stratum corneum and brisk interface inltrate with abundant dyskeratotic keratiFig. 7.29 Dermatomyositis: there is hyperkeratosis, epidermal atrophy, mild
basal vacuolar change and marked increase in dermal mucin. (From Luzar B,
Calonje E. Idiopathic connective tissue disorders. In: Calonje E, Brenn T, Lazar AJ,
Billings SD, eds. McKee’s Pathology of the Skin, 5th ed. Philadelphia: Elsevier;
2020, pp 771-825.)
Fig. 7.31 Acute graft-versus-host disease (GVHD), with vacuolar interface changes often extending along the hair follicles and adnexal structures. Though not entirely
specic for GVHD, satellite cell necrosis (juxtaposition of a lymphocyte next to a necrotic keratinocyte) may be observed.
nocytes scattered throughout the epidermis.
420

7.3 High-Yield Dermatopathology Differential Diagnoses
A B
Fig. 7.32 (A) and (B) Pityriasis lichenoides. At scanning magnication, there is a lichenoid lymphocytic inltrate with scale crust and occasional necrotic keratinocytes.
In the acute form (pityriasis lichenoides et varioliformis acuta), the inltrate is typically more dense and wedge-shaped, includes erythrocyte extravasation, and has
parakeratosis.
Table 7.15 Lichenoid Interface Dermatitis DDx
Lichen planus Orthohyperkeratosis, irregular acanthosis, V-shaped hypergranulosis , “saw-toothed” rete ridges, and apoptotic
Lichen planus-like keratosis (BLK) Like LP, but may have parakeratosis, eosinophils; frequently see solar lentigo/SK at periphery; often do not have as
Lichenoid drug eruption Looks like LP, but often has parakeratosis and deeper PV inflammatory infiltrate w/ eosinophils
Lichenoid GVHD Infiltrate less dense than LP, satellite cell necrosis , and epidermis often has chemotherapy effect/dysmaturation
Melanoma w/ lichenoid regression Search periphery for atypical melanocytic lesion; prominent pigment incontinence and plasma cells at regressed area
Lichen nitidus Small circumscribed papule, “ball and claw,” and epidermal collarette; dermal infiltrate is more mixed, consisting of
Lichen striatus
Lichenoid pigmented purpura Lichenoid and PV lymphocytic inflammation w/ RBC extravasation and hemosiderin deposition
Lichenoid secondary syphilis “Dirty” infiltrate (lymphocytes, neutrophils, histiocytes, nuclear debris, and plasma cells), slender elongated rete,
Hypertrophic lupus erythematosus Mistaken for SCC because of the hyperplastic follicular epithelium (unlike SCC, the interfollicular epidermis
keratatinocytes limited to lower levels of epidermis; lacks eosinophils (exceptions 5 hypertrophic LP, drug-
induced LP), lacks deep PV/PA inflammation
prominent saw-toothing or hypergranulosis
lymphocytes, histiocytes, and giant cells
Similar to LP, but w/ ↑ spongiosis and deep peri-eccrine inflammation ; usually young patients (solar elastosis rare)
swollen endothelial cells, superficial and deep inflammation
is typically normal-atrophic); lichenoid infiltrate resembles LP but has other features of lupus: deep PV/PA
inflammation, ↑ mucin, and BMZ thickening. Clusters of CD1231 plasmacytoid dendritic cells on IHC
Table 7.16 Weird Endophytic Neoplasms DDx
Poroma Uniform small cuboidal (“poroid”) cells; multifocal epidermal connections; eosinophilic cuticle in ducts (Fig. 7.33)
Trichilemmoma
Clear cell acanthoma Psoriasiform hyperplasia w/ neutrophils in corneum, sharply demarcated from surrounding normal epidermis (“looks
Panfolliculoma (cystic panfolliculoma) Benign, cystic (usually) follicular neoplasm with differentiation toward multiple components of hair follicle apparatus (Fig.7.36)
Pilar sheath acanthoma Acanthotic lobules attached to dilated pore (“dilated pore of Winer on steroids”) ( Fig. 7.37)
Tumor of follicular infundibulum Multiple slender connections to epidermis; fenestrated “ plate-like” architecture, fibrous stroma (Fig. 7.38)
Trichoepithelioma Basaloid tumor cells within highly cellular pink (fibroblast-rich) dermis; minimal to no epidermal attachment (vs. vast
Eccrine syringofibroadenoma Multiple epidermal connections; anastomosing thin strands of epithelial cells, ducts, and fibrovascular stroma (Fig. 7.40)
Lobular architecture, clear (glycogenated) cells w/ peripheral palisade and thick eosinophilic BMZ, 1/– squamous
eddies, 1/– verrucous surface (see Fig. 7.34)
exactly like psoriasis but with clear cells”) (Fig. 7.35)
majority of BCCs); papillary mesenchymal bodies and numerous horn cysts (many calcified) (see Fig. 7.39)
421

CHAPTER 7 • Dermatopathology
Fig. 7.33 Poroma. This scanning view shows anastomosing tumor islands with
eccrine differentiation that demonstrate multiple foci of attachment to the epidermis. Cells are monotonous, with more rounded nuclei than typical keratinocytes.
A
Fig. 7.34 Trichilemmoma. An exophytic verrucous growth pattern is associated
with a lobular perifollicular clear cell proliferation at the base of the lesion. (From
Prieto VG, Shea CR, Tok Celebi J, Busam KJ. Adnexal tumors. In: Busam KJ,
ed. Dermatopathology: A Volume in the Series: Foundations in Diagnostic Pa-
thology, 2nd ed. Philadelphia: Elsevier; 2016, pp 388-446.)
Fig. 7.35 Clear cell acanthoma. Although the basal epithelial cells retain their
normal tinctorial properties, most of the epithelium shows marked pallor. Intracorneal neutrophils and loss of the granular layer are frequent ndings.
B
Fig. 7.36 Panfolliculoma. Benign neoplasm with differentiation representing
various regions of the hair follicle. (A) Low power. (B) High power.
Fig. 7.37 Pilar sheath acanthoma. Tumor lobules, composed of outer root
sheath epithelium, radiate from a central depression. (From Patterson JW. Tumors of cutaneous appendages. In: Weedon’s Skin Pathology, 4th ed. Philadelphia: Elsevier; 2016, pp 903-965.)
422

Slightly pale keratinocytes
7.3 High-Yield Dermatopathology Differential Diagnoses
Horizontal bridge between
follicles
Fig. 7.38 Tumor of follicular infundibulum (From Rapini RP: Follicular neoplasms. In: Rapini RP, ed. Practical Dermatopathology, 3rd ed. Philadelphia: Elsevier; 2021,
pp 321-329.)
Fig. 7.39 Trichoepithelioma. There are multiple nests of basaloid cells, some
showing abortive hair follicle differentiation. (From Patterson JW. Tumors of cutaneous appendages. In: Weedon’s Skin Pathology. 5th ed. Philadelphia: Elsevier;
2021:951–1016).
Table 7.17 Paisley Tie (“Tadpole”) DDx
DTC Central dell, bland basaloid epithelial strands, numerous horn cysts (many w/ calcification), and fibroblast-rich pink
collagenous stroma; lacks: retraction, myxoid stroma, and perineural involvement (see Fig. 7.41)
MAC Deeply infiltrative tumor (into subcutis/skeletal muscle almost always) with bi-lineage differentiation: horn cysts (follicular)
and small syringoma-like ducts (sweat) in superficial dermis 1 infiltrative epithelial strands in deep dermis/SQ/skeletal muscle;
perineural invasion; scattered lymphoid nodules (see Fig. 7.42)
Syringoma Basaloid epithelial strands and ducts in fibrotic stroma; ducts contain amorphous eosinophilic debris; lacks follicular
differentiation (vs. MAC, DTE and BCC) (see Fig. 7.43)
Morpheaform BCC Sharply angulated strands of atypical basaloid cells in morphea-like stroma, numerous mitoses and apoptotic cells ; fewer
horn cysts and calcifications than DTE; lacks ductal differentiation (vs. MAC and syringoma) and lymphoid nodules (vs. MAC)
(Fig. 7.44)
Fig. 7.40 Eccrine syringobroadenoma: this lesion presented as a solitary tumor.
Arising from the epidermis are numerous anastomosing strands of epithelium
surrounded by a cellular brous stroma. (From Calonje E, Brenn T, Lazar AJ,
Billings SD. Tumors of the sweat glands. In: Calonje E, Brenn T, Lazar AJ, Billings
SD, eds. McKee’s Pathology of the Skin, 5th ed. Philadelphia: Elsevier; 2020,
pp 1611-1679.)
423

CHAPTER 7 • Dermatopathology
Fig. 7.41 Desmoplastic trichoepithelioma. Central dell, with paisley-tie epithelial
cords and epithelial cells demonstrating oval nuclei. Dermal calcium deposits
and cysts containing keratin. Usually on the head and neck.
Fig. 7.44 Morpheaform basal cell carcinoma. There is dermal brosis and keloidal collagen formation adjacent to the inltrative islands of tumor. The tumor
demonstrates peripheral palisading and single-cell necrosis. Mucinous stroma
can be scant. The tumor demonstrates epidermal connection.
Fig. 7.42 Microcystic adnexal carcinoma. Combination of cysts and ducts, with
deep extension into subcutis and underlying structures, as well as perineural
invasion, are features.
Table 7.18 Complex Cystic Proliferations (“Rolls and Scrolls”)
Proliferating pilar
cyst
Pilomatricoma Multilobulated dermal tumor; basaloid and
Table 7.19 Epidermoid Cyst Mimickers
Vellus hair cyst Small vellus hairs within cyst cavity
Dermoid cyst Complete array of adnexal structures (follicles,
Steatocystoma Sebaceous glands in cyst wall, eosinosphilic
Dense pink trichilemmal keratin within cyst cavities;
lacks granular layer; multilobular proliferations
of pink squamous cells; lacks anucleate ghost
cells or basaloid germinative cells
pink ghost cells within the tumor lobules;
calcification typically present 1/– ossification
sebaceous glands, and apocrine glands) inserting
in cyst wall
cuticle (“sharktooth” lining), and cyst cavity
appears empty and collapsed
Fig. 7.43 Syringoma. Ducts lined by eosinophilic cuticle and containing proteinaceous, amorphous material. “Tadpoles” with cuboidal nuclei limited to the dermis. (From Patterson JW. Tumors of Cutaneous Appendages. In: Weedon’s Skin
Pathology. 5th ed. Philadelphia: Elsevier; 2021, pp 951–1016.)
424
Соседние файлы в папке Библиотека им академика М.И. Перельмана
